ENGN
Price
$9.50
Change
+$0.05 (+0.53%)
Updated
Dec 26 closing price
Capitalization
636.35M
Intraday BUY SELL Signals
TBPH
Price
$18.84
Change
+$0.11 (+0.59%)
Updated
Dec 26 closing price
Capitalization
954.67M
64 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ENGN vs TBPH

Header iconENGN vs TBPH Comparison
Open Charts ENGN vs TBPHBanner chart's image
enGene Holdings
Price$9.50
Change+$0.05 (+0.53%)
Volume$438.78K
Capitalization636.35M
Theravance Biopharma
Price$18.84
Change+$0.11 (+0.59%)
Volume$211.02K
Capitalization954.67M
ENGN vs TBPH Comparison Chart in %
ENGN
Daily Signal:
Gain/Loss:
TBPH
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ENGN vs. TBPH commentary
Dec 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENGN is a Buy and TBPH is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 28, 2025
Stock price -- (ENGN: $9.50 vs. TBPH: $18.84)
Brand notoriety: ENGN and TBPH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENGN: 28% vs. TBPH: 41%
Market capitalization -- ENGN: $636.35M vs. TBPH: $954.67M
ENGN [@Biotechnology] is valued at $636.35M. TBPH’s [@Biotechnology] market capitalization is $954.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENGN’s FA Score shows that 1 FA rating(s) are green whileTBPH’s FA Score has 0 green FA rating(s).

  • ENGN’s FA Score: 1 green, 4 red.
  • TBPH’s FA Score: 0 green, 5 red.
According to our system of comparison, ENGN is a better buy in the long-term than TBPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENGN’s TA Score shows that 6 TA indicator(s) are bullish while TBPH’s TA Score has 3 bullish TA indicator(s).

  • ENGN’s TA Score: 6 bullish, 3 bearish.
  • TBPH’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ENGN is a better buy in the short-term than TBPH.

Price Growth

ENGN (@Biotechnology) experienced а +9.32% price change this week, while TBPH (@Biotechnology) price change was +0.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.36%. For the same industry, the average monthly price growth was +0.27%, and the average quarterly price growth was +54.56%.

Reported Earning Dates

TBPH is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Biotechnology (+0.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TBPH($955M) has a higher market cap than ENGN($636M). TBPH YTD gains are higher at: 100.213 vs. ENGN (42.857). TBPH has higher annual earnings (EBITDA): 53.1M vs. ENGN (-90.78M). TBPH has more cash in the bank: 330M vs. ENGN (202M). ENGN has less debt than TBPH: ENGN (31.4M) vs TBPH (44.6M). TBPH has higher revenues than ENGN: TBPH (80.3M) vs ENGN (0).
ENGNTBPHENGN / TBPH
Capitalization636M955M67%
EBITDA-90.78M53.1M-171%
Gain YTD42.857100.21343%
P/E RatioN/A33.05-
Revenue080.3M-
Total Cash202M330M61%
Total Debt31.4M44.6M70%
FUNDAMENTALS RATINGS
TBPH: Fundamental Ratings
TBPH
OUTLOOK RATING
1..100
39
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
87
SMR RATING
1..100
56
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
88
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ENGNTBPH
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
68%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
76%
Momentum
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
81%
MACD
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 12 days ago
87%
Bearish Trend 19 days ago
69%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
ENGN
Daily Signal:
Gain/Loss:
TBPH
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FHLFX15.170.02
+0.13%
Fidelity Series International Index
VMNVX31.710.02
+0.06%
Vanguard Global Minimum Volatility Admr
SOAVX38.590.01
+0.03%
Spirit of America Large Cap Value A
LGLVX58.42-0.04
-0.07%
Lord Abbett Growth Leaders R6
LSHCX23.16-0.56
-2.36%
Kinetics Spin-Off and Corp Rest Adv C

ENGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENGN has been loosely correlated with COGT. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ENGN jumps, then COGT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENGN
1D Price
Change %
ENGN100%
+0.53%
COGT - ENGN
48%
Loosely correlated
-2.14%
TBPH - ENGN
34%
Loosely correlated
+0.59%
TELO - ENGN
30%
Poorly correlated
+2.82%
TCRX - ENGN
29%
Poorly correlated
+1.92%
ATHE - ENGN
29%
Poorly correlated
+2.42%
More

TBPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, TBPH has been loosely correlated with VYGR. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if TBPH jumps, then VYGR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TBPH
1D Price
Change %
TBPH100%
+0.59%
VYGR - TBPH
40%
Loosely correlated
+0.25%
KYMR - TBPH
40%
Loosely correlated
-2.18%
TARA - TBPH
37%
Loosely correlated
+1.09%
VERA - TBPH
36%
Loosely correlated
-3.75%
LYRA - TBPH
36%
Loosely correlated
+0.28%
More